Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook
March 06, 2019 at 17:05 PM EST
Healthcare companies were among the worst performing stocks Wednesday, with biotechnology sector-specific ETFs taking the brunt of the hit, after FDA Commissioner Scott Gottlieb unexpectedly resigned, casting a cloud over policy changes ahead. On Wednesday, the Health Care Select Sector SPDR ETF...